This inventor holds 1 USPTO granted patent. Top assignee: Sutro Biopharma, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Andrew James Mcgeehan
Introduction
Andrew James Mcgeehan is a notable inventor recognized for his contributions to the field of biopharmaceuticals. He has made significant strides in developing innovative solutions that address critical medical challenges. His work is particularly focused on anti-tissue factor antibodies and their applications.
Latest Patents
Andrew holds a patent titled "ANTI-TISSUE FACTOR ANTIBODIES AND ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI-TISSUE FACTOR ANTIBODIES OR ANTIBODY CONJUGATES, AND METHODS OF MAKING AND USING ANTI-TISSUE FACTOR ANTIBODIES AND ANTIBODY CONJUGATES." This patent highlights his expertise in creating advanced therapeutic agents that can potentially improve patient outcomes.
Career Highlights
Currently, Andrew is employed at Sutro Biopharma, Inc., where he continues to push the boundaries of biopharmaceutical research. His work at the company has been instrumental in advancing the development of novel therapies. With a total of 1 patent, he has established himself as a key player in his field.
Collaborations
Andrew collaborates with talented individuals such as Robert Tian-Xuan Yuan and Daniel Calarese, contributing to a dynamic research environment. Their combined expertise fosters innovation and drives the development of groundbreaking solutions in biopharmaceuticals.
Conclusion
In summary, Andrew James Mcgeehan is a distinguished inventor whose work in anti-tissue factor antibodies has the potential to transform medical treatments. His contributions at Sutro Biopharma, Inc. and his collaborations with fellow researchers underscore his commitment to advancing healthcare solutions.